Purchase Order 75D30122P14922
Award Date
8/8/22
Potential Completion Date
8/7/23
Potential Value
$249K
Federal Agency
CDC Pittsburgh
Awardee
Genscript USA Inc.
Ultimate Awardee
Not listed
PSC Category
6640 - Laboratory Equipment And Supplies
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Piscataway, NJ 08854, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
2
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract awarded by the Department of Health and Human Services Centers for Disease Control and Prevention (HHS/CDC) to Genscript USA Inc., a for-profit biotechnology company, provides gene synthesis services. The $245,750.00 firm-fixed-price purchase order has a completion date of September 29, 2021 and was awarded on August 18, 2020. The contract does not have a set-aside designation. Genscript is a provider of gene synthesis, gene editing, custom protein and antibody...
The Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) awarded a firm-fixed-price purchase order contract to Genscript USA Inc., a for-profit biotechnology company, for gene synthesis services. The $163,750 contract has a completion date of September 30, 2019. Genscript is a provider of gene synthesis, gene editing, custom protein and antibody production, and other molecular biology services to support biomedical research and public health...
The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a firm fixed-price purchase order contract worth $246,699.00 to Genscript USA Inc., a for-profit biotechnology company. The contract is for the synthesis of plasmids and mutagenesis in support of research on critical vaccine viruses (CVV), with a completion date of September 22, 2024. Genscript, based in Piscataway, New Jersey, provides a range of molecular biology services to federal agencies,...
This firm fixed-price purchase order contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The $3,943.72 contract is for custom gene synthesis services to support NIAID's biomedical research programs. Genscript, a for-profit organization, has a strong track record of providing specialized molecular biology products and services to...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm fixed-price purchase order to Genscript USA Inc., a for-profit biotechnology company, for the development of murine hybridoma and V region sequencing, custom design chimeric plasmid, and custom proteins. The $249,785.00 contract has a completion date of September 29, 2022 and was awarded on September 30, 2021. Genscript is a provider of gene synthesis, gene editing, custom protein and antibody...
This is a firm fixed price purchase order contract awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Genscript USA Inc., a for-profit biotechnology company, for custom gene synthesis services. The contract has a potential value of $21,275.80 and a completion date of August 19, 2020. Genscript, based in Piscataway, New Jersey, specializes in gene synthesis, gene editing, custom protein and...
This firm fixed-price purchase order was awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to Genscript USA Inc., a for-profit biotechnology company, for the development of murine hybridoma and V region sequencing. The contract has a potential value of $174,903.00 and a completion date of July 14, 2021. Genscript is a provider of gene synthesis, gene editing, custom protein and antibody production, and other molecular biology services, which it has...
This federal contract award to Genscript USA Inc., a biotechnology company based in New Jersey, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services (HHS). The $4,196.16 firm fixed-price purchase order is for gene synthesis services. Genscript, a for-profit organization, has a history of providing a wide range of molecular biology products and services to...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm-fixed-price purchase order contract to Genscript USA Inc., a for-profit biotechnology company, for stable cell line development services with a completion date of April 1, 2020. The contract had a potential value of $130,400.99 and was not set aside for any particular business type. Genscript provides a range of molecular biology products and services, including gene synthesis, gene editing,...
This is a $8,073.05 firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services (HHS), to Genscript USA Inc., a biotechnology company in Piscataway, New Jersey. The contract is for the synthesis of a specific gene, HHSN272201200153P. Genscript, which is not a small business set-aside, has received numerous previous contracts from HHS agencies like the National Institutes of Health, Centers for...